Literature DB >> 11160760

Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans.

T H Rammsayer1.   

Abstract

In a double-blind crossover design, either 30 mg of the noncompetitive NMDA-receptor antagonist memantine or a placebo was administered to 40 healthy male volunteers. Twenty line drawings of objects and 20 photographs of unfamiliar faces were presented on a computer screen. After a retention interval of 80 min, the participants' task was to select the original objects and faces from a set of 80 items. Results were analyzed applying a signal-detection-theory approach. Recognition performance for objects was significantly impaired under memantine as compared to placebo, whereas performance on face recognition was not affected. Findings support the notion of differential effects of NMDA-receptor antagonists on memory functions in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160760      PMCID: PMC311354          DOI: 10.1101/lm.33701

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  54 in total

1.  Functional neuroanatomy of face and object processing. A positron emission tomography study.

Authors:  J Sergent; S Ohta; B MacDonald
Journal:  Brain       Date:  1992-02       Impact factor: 13.501

Review 2.  Excitatory amino acid receptors and synaptic plasticity.

Authors:  G L Collingridge; W Singer
Journal:  Trends Pharmacol Sci       Date:  1990-07       Impact factor: 14.819

Review 3.  Pharmacology of memory: cholinergic-glutamatergic interactions.

Authors:  T G Aigner
Journal:  Curr Opin Neurobiol       Date:  1995-04       Impact factor: 6.627

Review 4.  Contributory mechanisms in the causation of neurodegenerative disorders.

Authors:  G J Lees
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

5.  The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat.

Authors:  A Ennaceur; J P Aggleton
Journal:  Behav Brain Res       Date:  1997-11       Impact factor: 3.332

Review 6.  Schizophrenia and glutamatergic transmission.

Authors:  C A Tamminga
Journal:  Crit Rev Neurobiol       Date:  1998

7.  The use of diurnal vigilance changes in the EEG to verify vigilance-enhancing effects of memantine in a clinical pharmacological study.

Authors:  H Schulz; M Jobert; R Coppola; W M Herrmann; M Pantev
Journal:  Neuropsychobiology       Date:  1996       Impact factor: 2.328

8.  Varieties of functional deficits in prosopagnosia.

Authors:  J Sergent; J L Signoret
Journal:  Cereb Cortex       Date:  1992 Sep-Oct       Impact factor: 5.357

9.  Prosopagnosia: a face-specific disorder.

Authors:  J E McNeil; E K Warrington
Journal:  Q J Exp Psychol A       Date:  1993-02

Review 10.  From sensation to cognition.

Authors:  M M Mesulam
Journal:  Brain       Date:  1998-06       Impact factor: 13.501

View more
  17 in total

Review 1.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

2.  A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists.

Authors:  Sophie Dix; Gary Gilmour; Slavinka Potts; Janice W Smith; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

3.  A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.

Authors:  Janice W Smith; Francois Gastambide; Gary Gilmour; Sophie Dix; Julie Foss; Kirstie Lloyd; Nadia Malik; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

Review 4.  Memantine: a review of its use in Alzheimer's disease.

Authors:  Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  Memantine.

Authors:  Blair Jarvis; David P Figgitt
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  The effects of the glutamate antagonist memantine on brain activation to an auditory perception task.

Authors:  Heidi van Wageningen; Hugo A Jørgensen; Karsten Specht; Tom Eichele; Kenneth Hugdahl
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

7.  Selective neuronal vulnerability to oxidative stress in the brain.

Authors:  Xinkun Wang; Elias K Michaelis
Journal:  Front Aging Neurosci       Date:  2010-03-30       Impact factor: 5.750

8.  Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.

Authors:  David Cheng; Jac Kee Low; Warren Logge; Brett Garner; Tim Karl
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

9.  Contribution of N-methyl-D-aspartate receptors to attention and episodic spatial memory during senescence.

Authors:  Michael Guidi; Asha Rani; Semir Karic; Barrett Severance; Ashok Kumar; Thomas C Foster
Journal:  Neurobiol Learn Mem       Date:  2015-07-30       Impact factor: 2.877

10.  The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.

Authors:  Valeriy G Ostapchenko; Megan Chen; Monica S Guzman; Yu-Feng Xie; Natalie Lavine; Jue Fan; Flavio H Beraldo; Amanda C Martyn; Jillian C Belrose; Yasuo Mori; John F MacDonald; Vania F Prado; Marco A M Prado; Michael F Jackson
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.